TETRAHYDROPIPERINE

CAS No. 23434-88-0

TETRAHYDROPIPERINE( Cosmoperine )

Catalog No. M20421 CAS No. 23434-88-0

TETRAHYDROPIPERINE is a natural product derived from piperine can be used to treat convulsion epilepsy relieve pain and control insects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 33 In Stock
50MG 48 In Stock
100MG 68 In Stock
200MG 99 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TETRAHYDROPIPERINE
  • Note
    Research use only, not for human use.
  • Brief Description
    TETRAHYDROPIPERINE is a natural product derived from piperine can be used to treat convulsion epilepsy relieve pain and control insects.
  • Description
    TETRAHYDROPIPERINE is a natural product derived from piperine can be used to treat convulsion epilepsy relieve pain and control insects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Cosmoperine
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    Htrpv1|CYP450
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23434-88-0
  • Formula Weight
    289.37
  • Molecular Formula
    C17H23NO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:57 mg/mL (196.97 mM)
  • SMILES
    O=C(CCCCc1ccc2OCOc2c1)N1CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Edwin Andrés Correa H?Gest?Tt E D Sterner O et al. In vitro TRPV1 activity of piperine derived amides[J]. Bioorganic & Medicinal Chemistry 2010 18(9):3299-3306.
molnova catalog
related products
  • TRPM4-IN-1

    TRPM4-IN-1 is a potent and selective inhibitor of TRPM4 with an IC50 of 1.5 μM.

  • Vitexin

    Vitexin protects brain against cerebral I/R injury, and this effect may be regulated by mitogen-activated protein kinase (MAPK) and apoptosis signaling pathways.

  • UNC-2025

    UNC-2025( IC50 of 0.74 nM and 0.8 nM) is a potent and orally bioavailable dual MER/FLT3 inhibitor. UNC-2025 is about 20-fold selectivity higher than Axl and Tyro3.